517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial

ABSTRACT:

SUBMITTER: Branch-Elliman W 

PROVIDER: S-EPMC8690689 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature